Autopsy report · NCT00176475
Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease
Cause of deathSlow enrollment
“slow accrual”
Life of this trial
- Registered 8 months after it had already started.
- Ran for about 3 years 1 month before it stopped.
- 2 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- University of Medicine and Dentistry of New Jersey
- Sponsor type
- University, hospital or other
- Conditions
- Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm
- Interventions
- rituximab; therapeutic allogeneic lymphocytes
- Participants
- 2
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.